CA3072648A1 - Substituted benzimidazoles as potassium channel inhibitors - Google Patents
Substituted benzimidazoles as potassium channel inhibitors Download PDFInfo
- Publication number
- CA3072648A1 CA3072648A1 CA3072648A CA3072648A CA3072648A1 CA 3072648 A1 CA3072648 A1 CA 3072648A1 CA 3072648 A CA3072648 A CA 3072648A CA 3072648 A CA3072648 A CA 3072648A CA 3072648 A1 CA3072648 A1 CA 3072648A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- amino
- phenyl
- trifluoromethyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17020353 | 2017-08-14 | ||
| EP17020353.3 | 2017-08-14 | ||
| PCT/EP2018/071911 WO2019034603A1 (en) | 2017-08-14 | 2018-08-13 | SUBSTITUTED BENZIMIDAZOLES USEFUL AS INHIBITORS OF THE POTASSIUM CHANNEL |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3072648A1 true CA3072648A1 (en) | 2019-02-21 |
Family
ID=59699444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3072648A Pending CA3072648A1 (en) | 2017-08-14 | 2018-08-13 | Substituted benzimidazoles as potassium channel inhibitors |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11098018B2 (https=) |
| EP (1) | EP3668841A1 (https=) |
| JP (1) | JP7158464B2 (https=) |
| CN (1) | CN111344281B (https=) |
| CA (1) | CA3072648A1 (https=) |
| WO (1) | WO2019034603A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3013237A1 (en) * | 2016-02-24 | 2017-08-31 | Acesion Pharma Aps | Novel potassium channel inhibitors |
| EP3672953B1 (en) * | 2017-08-23 | 2021-07-28 | Acesion Pharma ApS | Benzimidazole derivatives useful as potassium channel inhibitors |
| WO2022200162A1 (en) * | 2021-03-22 | 2022-09-29 | Acecion Pharma Aps | Novel potassium channel inhibitors |
| EP4245753A1 (en) * | 2022-03-17 | 2023-09-20 | Acesion Pharma ApS | Imidazole derivatives as potassium channel inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005030726A1 (en) * | 2003-09-23 | 2005-04-07 | Merck & Co., Inc. | Isoquinolinone potassium channel inhibitors |
| JP4794446B2 (ja) * | 2003-09-23 | 2011-10-19 | メルク・シャープ・エンド・ドーム・コーポレイション | イソキノリン系カリウムチャンネル阻害薬 |
| AU2005268782A1 (en) | 2004-08-05 | 2006-02-09 | Neurosearch A/S | 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| US7842817B2 (en) | 2005-01-11 | 2010-11-30 | Neurosearch A/S | 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| WO2008113747A1 (en) * | 2007-03-22 | 2008-09-25 | Neurosearch A/S | Medicaments useful as potassium channel modulators |
| AR090037A1 (es) * | 2011-11-15 | 2014-10-15 | Xention Ltd | Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio |
| WO2013104577A1 (en) | 2012-01-11 | 2013-07-18 | Acesion Pharma Aps | Benzimidazolyl-acetamide derivatives useful as potassium channel modulators |
| CA3013237A1 (en) * | 2016-02-24 | 2017-08-31 | Acesion Pharma Aps | Novel potassium channel inhibitors |
-
2018
- 2018-08-13 EP EP18750455.0A patent/EP3668841A1/en active Pending
- 2018-08-13 JP JP2020508323A patent/JP7158464B2/ja active Active
- 2018-08-13 WO PCT/EP2018/071911 patent/WO2019034603A1/en not_active Ceased
- 2018-08-13 CA CA3072648A patent/CA3072648A1/en active Pending
- 2018-08-13 US US16/638,590 patent/US11098018B2/en active Active
- 2018-08-13 CN CN201880065901.5A patent/CN111344281B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020530479A (ja) | 2020-10-22 |
| EP3668841A1 (en) | 2020-06-24 |
| JP7158464B2 (ja) | 2022-10-21 |
| CN111344281A (zh) | 2020-06-26 |
| WO2019034603A1 (en) | 2019-02-21 |
| US11098018B2 (en) | 2021-08-24 |
| CN111344281B (zh) | 2023-11-14 |
| US20200216398A1 (en) | 2020-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2756512C1 (ru) | Пролекарства кетамина, его композиции и применения | |
| FI104069B (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-(fenyyli- tai sykloalkyyli)-3-hydroksi-1-fenyylisulfonyyli-2-indoliinikarboksamidijohdannaisten valmistamiseksi | |
| CA3072648A1 (en) | Substituted benzimidazoles as potassium channel inhibitors | |
| KR20170095964A (ko) | Hdac1/2 억제제로서 피페리딘 유도체 | |
| US11274092B2 (en) | Potassium channel inhibitors | |
| AU2006279991A1 (en) | Substituted imidazole compounds as KSP inhibitors | |
| US11168074B2 (en) | Potassium channel inhibitors | |
| US12030856B2 (en) | Potassium channel inhibitors | |
| JP7853995B2 (ja) | 新規カリウムチャネル阻害剤 | |
| US11945811B2 (en) | Potassium channel inhibitors | |
| HK1078796A1 (en) | 1h-1,2,4-triazole-3-carboxamide derivatives as cannabinoid-cb1 receptor ligands | |
| HK1078796B (en) | 1h-1,2,4-triazole-3-carboxamide derivatives as cannabinoid-cb1 receptor ligands |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20230802 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD Year of fee payment: 6 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240809 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20240809 Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20240809 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20240819 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20241219 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250211 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250613 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250613 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 7TH ANNIV.) - STANDARD Year of fee payment: 7 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250808 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250808 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D149 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S INTERVIEW Effective date: 20251023 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT Effective date: 20251202 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20251205 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20251205 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20251205 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D22-D128 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALLOWANCE REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260416 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260416 |